| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |